Lincare Recalls Vancomycin HCl in Dextrose Due to Sterility Concerns
Lincare, Inc. is recalling Vancomycin HCl in Dextrose compounded by United Medical IV Center because the sterility of the product is not assured.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant risk of harm (lack of sterility assurance) corresponds to a severity score of 4 (Severe).
Plain-English summary
Lincare, Inc. is recalling Vancomycin HCl in Dextrose, VANCOMYCIN 750mg / D5W 150mL, Qty: 6 150 mL Bags. The product was compounded by United Medical IV Center in Little Rock, Arkansas, and distributed in the United States, including Arkansas.
The recall was initiated because the sterility of the product is not assured. The specific lot was compounded on 05/29/15 and has a discard after date of 06/10/15.
Consumers and healthcare providers should stop using the affected product and contact Lincare, Inc. or their healthcare provider for further instructions.
The recalled product
- Product
- Vancomycin HCl in Dextrose, VANCOMYCIN 750mg / D5W 150mL, Qty: 6 150 mL Bags, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.
- Manufacturer
- Lincare, Inc.
- Category
- Drug — IV Infusion
- Hazard
- Affected units
- 6
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Compounded on 05/29/15
- Discard After: 06/10/15
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 54 recalled by Lincare, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 54 products in this recall →Related recalls
Same manufacturer · Lincare, Inc.
See all →- SevereLincare Recalls Ganciclovir Sodium Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Penicillin G Potassium IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Hydrocodone IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls TPN 3:1 Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Ceftazidime IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharmakon Recalls Vancomycin HCL 1.25 GM Bags Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- HighVancomycin Dextrose Injectable Recalled Due to Sterility Concerns
FDA (Drugs) · 2023-05-31
- HighVancomycin and Dextrose Injection Sterility Recall by Central Admixture
FDA (Drugs) · 2023-05-31
- HighVancomycin IV Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-08-09
- SevereBaptist Health Recalls Vancomycin IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- SevereSCA Pharmaceuticals Recalls Vancomycin IV Bags Due to Particulate Matter
FDA (Drugs) · 2017-04-12